New hope for kids with tough cancer: Two-Year pill aims to keep neuroblastoma away
NCT ID NCT07278674
Summary
This study is testing whether taking the drug eflornithine for two years can help keep cancer from coming back in children with high-risk neuroblastoma who have already finished their main treatments, including immunotherapy. Researchers will follow 20 children under 18 to see if this maintenance therapy improves survival and is safe. The goal is to control the disease long-term after initial treatment is complete.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH-RISK NEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ruijin Hospital Hainan Branch, affiliated with Shanghai Jiao Tong University School of Medicine and Children's Hospital of Shanghai, affiliated with Shanghai Jiao Tong University School of Medicine
Hainan, China
Conditions
Explore the condition pages connected to this study.